Immunogenicity
Serum concentrations of ADAs against the drug were measured using a validated electrochemiluminescence ligand binding assay with sensitivity of 80.7 ng/mL and precision (coefficient of variation) of ≤ 16.1%. Samples proving positive in the ADA assay were further characterized for assessments of ADA titer and the presence of neutralizing antibodies.